Livivos

04/09/2024

Livivos, Inc. announces appointment of Mr. Jerry Mabary as Director of Commercialization.
We are thrilled to announce the appointment of Mr. Jerry Mabary as Livivos's Director of Commercialization! Mr. Mabary brings a wealth of expertise to support the introduction of the LiverScope, Livivos's transformative point of care liver disease diagnostic device.

https://www.einnews.com/pr_news/701931020/livivos-inc-announces-appointment-of-mr-jerry-mabary-as-director-of-commercialization

www.livivos.com

11/08/2023

Livivos, Inc. announces appointment of Dr. Julio Gutierrez as Director of Clinical Development. https://world.einnews.com/pr_news/667045560/livivos-inc-announces-appointment-of-dr-julio-gutierrez-as-director-of-clinical-development

We are thrilled to announce the appointment of Dr. Julio Gutierrez as Livivos's Director of Clinical Development. Dr. Gutierrez brings a wealth of expertise to support our innovative diagnostic initiatives.

www.livivos.com Julio Gutierrez MD.

10/03/2023

Meet with us at the Medtech Conference in Anaheim, California! October 9-11. We love sharing the progress with the LiverScope®, our market-disruptive accurate liver disease diagnostic device.
Book your meeting with the Medtech Conference app.


www.livivos.com

LiverScope® is an investigational device. Limited by Federal law to investigational use.

09/13/2023

https://www.globenewswire.com/news-release/2023/09/13/2742550/0/en/Madrigal-Pharmaceuticals-Announces-NDA-Acceptance-and-Priority-Review-of-the-New-Drug-Application-for-Resmetirom-for-the-Treatment-of-NASH-with-Liver-Fibrosis.html

CONSHOHOCKEN, Pa., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing...

08/22/2023

Coming up next week! The Magnetic Resonance methodologies introduced with the LiverScope® will be showcased at the International Conference on Magnetic Resonance Microscopy (ICMRM) in Singapore (August 27-31, 2023). https://icmrm2023.sciencesconf.org/
Stay updated at www.livivos.com for more about the LiverScope®'s journey.

Livivos, Inc

07/19/2023

Exciting news! The Magnetic Resonance methodologies introduced with the ® will be showcased at the International Conference on Magnetic Resonance Microscopy (ICMRM) in Singapore (August 27-31, 2023). This conference aims to promote recent advancements in high-resolution, spatially resolved Magnetic Resonance methods and applications. https://lnkd.in/gMRD8HQ2
Livivos's CEO, Pablo Prado, Ph.D., will present the innovative point-of-care modalities entering clinical diagnostics, focusing on pioneering MR technologies to measure indicators of liver disease - current and upcoming biomarkers. Stay updated at www.livivos.com for more about the LiverScope®'s journey.

Livivos, Inc

07/13/2023

Introducing , transformative liver disease diagnostics

05/04/2023

Livivos is excited to announce the kickoff of a clinical study of our LiverScope® device. Read about it here https://tinyurl.com/2p9erh5e, and and give us a like while you're visiting!

04/23/2023

Livivos CEO Dr. Pablo Prado offers a detailed update on Livivos's progress.

Livivos is embarking on an exciting journey!... fueled by a strong belief that accurate and broadly-accessible liver disease diagnosis has the potential to be…

03/20/2023

See you in Dana Point! Livivos is attending.
If you are attending this week's Life Science Intelligence (LSI) summit, let's meet to discuss Livivos's business progress and the introduction of our transformative point of care liver disease diagnostic device. http://livivos.com/

LSI USA 2023 is bringing together leading innovators and active investors. https://www.lifesciencemarketresearch.com/medtech-summit-2023

02/26/2023

Great news! Livivos has been selected to pitch at the upcoming MedTech Innovator meeting in Los Angeles. The aims to "improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system".
Out of over 1,000 companies that applied, Livivos was chosen as one of the 200 to present. We are thrilled to have the opportunity to showcase our game-changing approach to improving healthcare delivery.
https://medtechinnovator.org/
Learn about the LiverScope, point of care liver disease diagnostics: www.livivos.com

01/18/2023

Livivos is excited to be working with Pfizer on an investigational study of its LiverScope® device. Read about it here: https://www.linkedin.com/feed/update/urn:li:activity:7021493714309042176 and follow Livivos on LinkedIn!

01/04/2023

We are excited to share Livivos's business progress at the Biotech Showcase in San Francisco, January 9 to 11.
Learn more about our point of care liver disease diagnostic technology... at www.livivos.com.

11/27/2022

Livivos's CMO Dr. Claude Sirlin will be holding an educational session on our LiverScope® scanner at in Chicago on Nov. 29, 2022. Read more on LinkedIn: https://tinyurl.com/2p8fjrv6 and follow us to stay up to date!

11/21/2022

Livivos will be presenting at the upcoming Biotech Showcase in San Francisco, Jan. 9-11, 2023. Read about it here: https://tinyurl.com/598c2bjh

11/07/2022

Livivos's CEO Dr. Pablo Prado is at the AASLD Liver Meeting explaining our LiverScope device. You can see our booth here:

11/03/2022

Livivos's COO Dean Irwin will be representing Livivos as one of three presenters at the American Diabetes Association's 2022 Silicon Valley Leaders Forum HealthTech Showcase at the San Mateo Marriott tomorrow, Nov. 4! Read about it here:

500 million+ members | Manage your professional identity. Build and engage with your professional network. Access knowledge, insights and opportunities.

11/01/2022

Livivos will be attending AASLD's 2022 Liver Meeting Nov. 4-8. Read about it here:

Come see us at booth 640 at , The Liver Meeting. https://lnkd.in/eVXAzFwz, and learn about the . , , .